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Abstract
Partetravirus is a recently described group of animal parvoviruses which include the human partetravirus, bovine
partetravirus and porcine partetravirus (previously known as human parvovirus 4, bovine hokovirus and porcine hokovirus
respectively). In this report, we describe the discovery and genomic characterization of partetraviruses in bovine and ovine
samples from China. These partetraviruses were detected by PCR in 1.8% of bovine liver samples, 66.7% of ovine liver
samples and 71.4% of ovine spleen samples. One of the bovine partetraviruses detected in the present samples is
phylogenetically distinct from previously reported bovine partetraviruses and likely represents a novel genotype. The ovine
partetravirus is a novel partetravirus and phylogenetically most related to the bovine partetraviruses. The genome
organization is conserved amongst these viruses, including the presence of a putative transmembrane protein encoded by
an overlapping reading frame in ORF2. Results from the present study provide further support to the classification of
partetraviruses as a separate genus in Parvovirinae.
Citation: Tse H, Tsoi H-W, Teng JLL, Chen X-C, Liu H, et al. (2011) Discovery and Genomic Characterization of a Novel Ovine Partetravirus and a New Genotype of
Bovine Partetravirus. PLoS ONE 6(9): e25619. doi:10.1371/journal.pone.0025619
Editor: Jianming Qiu, University of Kansas Medical Center, United States of America
Received April 1, 2011; Accepted September 8, 2011; Published September 27, 2011
Copyright:  2011 Tse et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work is partly supported by the HKSAR Research Fund for the Control of Infectious Diseases of the Health, Welfare and Food Bureau (project
no.: 08070712) (http://www.fhb.gov.hk/grants/english/funds/funds_rfcid/funds_rfcid_abt/funds_rfcid_abt.html); Research Grants Council grant (http://www.ugc.
edu.hk/eng/rgc/index.htm); University Development Fund, and Outstanding Young Researcher Award, The University of Hong Kong (http://www.hku.hk/rss/
index4.htm); The Tung Wah Group of Hospitals Fund for Research in Infectious Diseases; and the Providence Foundation Limited in memory of the late Dr. Lui Hac
Minh. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: kyyuen@hkucc.hku.hk
Introduction
The parvoviruses are a group of small, non-enveloped animal
viruses with a single-stranded DNA genome between 4 and 6 kb in
size [1]. At least 2 open reading frames (ORF) are present in the
parvovirus genome, with ORF1 encoding the non-structural
proteins and ORF2 encoding the viral capsid proteins. Some
parvovirus genomes may contain an additional ORF encoding for
other proteins, such as the non-structural protein NP1 found in
human bocavirus and bovine parvovirus. Under the current
International Committee on Taxonomy of Viruses (ICTV) classifi-
cation system, the Parvoviridae are divided into two subfamilies based
on their host range: the Parvovirinae which infect vertebrates, and the
Densovirinae which mainly infect insects and other arthropods. The
Parvovirinae are further subdivided into 5 genera: the amdoviruses,
bocaviruses, dependoviruses, erythroviruses, and the parvoviruses.
Novel parvoviruses discovered in recent years, such as the human
partetravirus (previously known as human parvovirus 4 or PARV4)
[2], are not included in the current classification system, and will be
addressed by the ICTV in an upcoming update.
Some human parvoviruses are well-known pathogens associated
with a range of diseases in infected patients. Parvovirus B19 (also
known as erythrovirus B19) can cause syndromes ranging from
erythema infectiosum in children to late intrauterine death in
pregnant women. The human bocavirus, a parvovirus discovered
only in 2005, was associated with respiratory disease and could be
detected in stool of children [3,4,5,6,7,8], although clear
assessment of its pathogenicity is confounded by the frequent co-
detection of other respiratory viruses [9,10] and its presence in the
stool of healthy children. On the other hand, the human
partetravirus was initially discovered in patients suffering from
acute viral syndrome [2], but its association with clinical disease
has yet to be confirmed despite positive PCR detection in blood
products, HIV-infected patients, intravenous drug users, trans-
plant patients and blood donors in different localities
[11,12,13,14,15,16,17,18].
Since the discovery of the human partetravirus, related animal
viruses have been found in various mammalian species. We first
reported the discovery of porcine and bovine partetraviruses (also
known as hokoviruses previously), which are novel related animal
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parvoviruses found in Hong Kong [19]. Closely related porcine
partetraviruses have since been found in German wild boar
populations [20], while human partetravirus-like viral DNA was
detected in the plasma samples of a chimpanzee and baboon in
Cameroon [21]. As the genetic distances between human
partetravirus and other known parvoviruses at the time of its
discovery were relatively large, it was unclear if the human
partetravirus had diverged from a human parvovirus ancestor
early in the history of parvovirus evolution or if it had diverged
from an undiscovered animal parvovirus. Parvovirus evolution is
characterized by the development of host-specificity and congru-
ent viral and host phylogenies [22], which has led to the hypothesis
of long-term co-evolution of parvoviruses and their hosts. In
addition, evolutionary rates can vary significantly among different
parvovirus species [23,24], which complicates evolutionary
analysis between distant parvoviruses. Hence, the identification
of related partetraviruses in animals has contributed to our
knowledge of the evolutionary history of the human partetravirus.
As part of our ongoing program in the discovery of viruses
associated with emerging infections, we continued our surveillance
for novel partetraviruses in animals closely related to humans. In
the present study, bovine and ovine samples were selected for
targeted screening, as both domestic cattle and sheep are
important food animals in Southern China. PCR screening of
the animal samples identified a novel ovine partetraviruses as well
as a new genotype of bovine partetravirus, and their nearly full-
length genome sequences were obtained. Genomic and phyloge-
netic analyses of the new viruses confirmed them to be closely
related to the previously identified partetraviruses.
Materials and Methods
Collection of animal samples
All specimens were collected over a one year period (Sept 2008
to Aug 2009). A total of 110 bovine liver samples, 14 ovine spleen
samples and 9 ovine liver samples were collected from local food
markets with the assistance of the Veterinary Public Health
Section, the Food and Environmental Hygiene Department, and
the Agriculture, Fisheries and Conservation Department, the
Government of Hong Kong Special Administrative Region
(HKSAR). It should be noted that ovine liver and spleen samples
were not uniformly sampled throughout the study period due to
supply issues. All animals from which the specimens had been
obtained have passed the relevant health inspection to certify its
meat and other products as fit for human consumption.
Precautions taken to avoid cross contamination include the use
of disposable scalpels during tissue dissection and the collection of
samples only from the centre of each tissue block after surface
decontamination. Disposable protective gloves were also used and
changed after processing each tissue sample.
PCR detection of parvoviruses
DNA was extracted from all samples using QIAamp DNA Mini
kit (Qiagen) according to manufacturer’s instructions, and then
subjected to PCR using 2 different sets of screening PCR primers.
The primer sequences are: forward primer A 59- CCCGCKAS-
TACWGGNAARAC -39 and reverse primer A 59- CCGTAAYT-
CKRCCYTCKTCCCA -39 (targeting a 148 bp fragment); forward
primer B 59-TCTGCTATTGTAATHAARGAYGT-39 and re-
verse primer B 59-AAACACTCTGCRTCRTGRTGYTC-39 (tar-
geting a 293 bp fragment). The primers were designed from
multiple alignments of the nucleotide sequences of VP2 regions of
PARV4 and related parvoviruses using our previously described
strategy [19]. The PCR mixture (25 ml) contained DNA extracted
from samples, PCR buffer (10 mMTris/HCl pH 8.3, 50 mMKCl,
2 mM MgCl2 and 0.01% gelatin), 200 mM of each dNTP and
1.0 U AmpliTaq Gold polymerase (Applied Biosystems). PCR
cycling conditions were as follows: hot start at 94uC for 7 min,
followed by 50 cycles of 94uC for 1 min, 50uC for 1 min and 72uC
for 1 min with a final extension at 72uC for 10 min in an automated
thermal cycler (Applied Biosystems). Standard precautions were
taken to avoid PCR contamination and no false positive results was
observed in negative controls.
PCR products were gel-purified using the QIAquick gel
extraction kit (Qiagen). Both strands of the PCR products were
sequenced twice with an ABI Prism 3700 DNA Analyser (Life
Technologies) by using the PCR primers as sequencing primers.
The sequences of the PCR products were searched against known
VP2 sequences of parvoviruses in the National Center for
Biotechnology Information (NCBI) GenBank database using
BLASTN and TBLASTN.
Genome sequencing
Nearly full-length genome sequences spanning the entire
protein-coding regions were determined for 2 bovine and 4 ovine
strains of the PARV4-related parvoviruses identified in the present
study by using our genome sequencing strategy [19]. Briefly, DNA
extracted from the corresponding specimens was used as template
and amplified by degenerate primers designed from multiple
alignment of PARV4 and related sequences available in NCBI
GenBank. Additional primers were designed from the first and
subsequent rounds of sequencing. Non-overlapping regions were
confirmed by independent PCR and sequencing reactions by using
specific primers, and no sequence discrepancies were found
between repeated sequencing of any region. Sequences of genome
amplification and sequencing primers are available from the
authors upon request. For sequencing of the terminal regions, a
modified protocol for rapid amplification of cDNA ends was
adopted [25]. Sequences were assembled and manually edited to
produce final sequences of the viral genomes.
Phylogenetic and sequence analysis
Open reading frames were located using the ORF Finder tool at
NCBI (http://www.ncbi.nlm.nih.gov/projects/gorf/) and by com-
parison with the genome annotations of PARV4 and partetra-
viruses. Prediction of transmembrane domains was performed using
TMHMM version 2.0 server (http://www.cbs.dtu.dk/services/
TMHMM/) [26]. Functional annotation of predicted proteins was
performed by BLAST similarity search against annotations in the
NCBI RefSeq database, as well as by using the InterProScan search
tool (http://www.ebi.ac.uk/Tools/pfa/iprscan/) [27]. Multiple
alignments of sequences for phylogenetic analysis were constructed
using MUSCLE version 3.8.31 [28], and phylogenetic informative
regions were extracted using BMGE [29]. Maximum-likelihood
phylogenetic trees were constructed using PHYML version 3 [30],
under the best-fit protein evolution model as selected by ProtTest 3
[31]. Recombination detection was performed using bootscan
analysis (as implemented in SimPlot) [32] and GARD [33]. Sites
under positive selection were inferred by consensus between the
single-likelihood ancestor counting (SLAC), fixed effects likelihood
(FEL) and random effects likelihood (REL) methods as implemented
on the DataMonkey server (http://www.datamonkey.org) [34]. A
p-value of ,0.1 is considered to be statistically significant for the
positive selection analysis.
Nucleotide sequence GenBank accession numbers
The nucleotide sequences of the nearly full-length genomes of
the PARV4-related viruses have been submitted to NCBI
Novel Partetraviruses in Sheep and Cattle
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GenBank, and are available under the accession numbers
JF504697 – JF504702.
Results
Detection of parvovirus DNA in bovine and ovine
samples
PCR detection of PARV4-like DNA using screening primer set
A was positive for 2 out of 110 (1.8%) bovine liver samples, while
PCR using screening primer set B was positive for 10 out of 14
(71.4%) ovine spleen samples and 6 out of 9 (66.7%) ovine liver
samples. The rate of positive PCR detection is significantly higher
in ovine liver samples than in bovine live samples (by Fisher’s exact
test; p,0.001), while no statistically significant difference was
noted between ovine liver and ovine spleen samples (by Fisher’s
exact test; p.0.05). Sequencing of the PCR products was
performed: sequences from the two positive bovine liver samples
showed the highest nucleotide identities (100% and 89%) to the
ORF2 of bovine partetravirus HK2 (GenBank accession
no. EU200670), and sequences from the positive ovine samples
showed the highest nucleotide identity (88%) to the ORF2 of
human partetravirus PARV4 strain BONN-14 (GenBank acces-
sion no. EU175857). This suggested that two related but distinct
strains of partetravirus are present in the two different bovine
samples, while a novel partetravirus is present in the ovine
samples.
Genome organization and coding potential
The nearly full-length genomes of 2 strains of bovine
partetravirus (5096–5240 nucleotides) and 4 strains of ovine
partetravirus (2 from liver samples and 2 from spleen samples)
(5249 nucleotides) were determined. Similar to our earlier attempt
at sequencing the complete genomes of other PARV4-like animal
parvoviruses [19], the obtained genome lengths were shorter than
expected, as sequencing of the ends of the genomes was hampered
by the presence of extensive hairpin structures. Pairwise
comparison of the genome sequences of the parvoviruses was
performed. Among the presently identified bovine partetraviruses,
HK4 was highly similar (99.3299.4% nucleotide sequence
identity) to the bovine partetraviruses reported previously, while
HK5 showed much greater sequence divergence (90.0–90.1%
nucleotide sequence identity). The genome sequences of the ovine
parvoviruses were 100% identical, and they exhibited 68.2–68.3%
nucleotide sequence identities to that of the bovine partetraviruses
and around 64.0% nucleotide sequence identities to that of the
porcine partetraviruses. Results of further sequence comparison
with related parvoviruses were shown in Tables 1 and 2.
All sequenced virus strains possessed a genome organization
typical of parvoviruses. There were two large non-overlapping
ORFs, with ORF1 encoding a non-structural polyprotein NS1 and
ORF2 encoding overlapping VP1/VP2 capsid proteins and a
small conserved putative protein. A small non-coding gap of
around 115 nucleotides was found between the two ORFs.
Inverted terminal repeats were found at the 59 and 39 ends of the
viral genome. Further sequence analysis was not performed for the
bovine partetravirus HK4 due to its high genetic similarity with
previously characterized bovine partetraviruses. For bovine
partetravirus HK5, the predicted NS1 protein consists of 652 aa
and is 73.9 kDa in molecular weight. Conserved sequence features
including helicase and ATPase domains are present, in agreement
with the non-structural functional role of NS1 in parvovirus
replication. The VP1 protein is predicted to contain 931 aa and is
102.8 kDa in molecular weight, which is comparable to that of
previously identified bovine partetraviruses and larger than the
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average molecular weight of VP1 in other parvoviruses. Conserved
functional motifs like phospholipase A2 were identified in the VP1
unique (VP1u) region. For the ovine parvovirus, the predicted NS1
protein consists of 656 aa and is 74.2 kDa in molecular weight,
while its VP1 protein contains 933 aa and is 103.2 kDa in
molecular weight. Both proteins contain the same conserved
functional motifs as their homologs in bovine partetravirus HK5.
Similar to other partetraviruses, there exists a putative third
ORF in a different reading frame within the VP1u region for both
bovine partetravirus HK5 and ovine parvovirus. In agreement
with previous studies, the phospholipase A2 motifs of ORF2 are
found in the VP1u region, which is also the most conserved region
among partetraviruses [19,35]. The putative third ORF encodes a
small protein containing a single transmembrane helix spanning
20 aa in the centre, with predicted molecular weights of 9.5 kDa in
bovine partetravirus HK5 and 9.7 kDa in ovine parvovirus. The
aa sequences of this putative protein are conserved among human,
bovine, ovine and porcine partetraviruses, with pairwise sequence
identities ranging from 59.3% (between porcine partetravirus
HK7 and ovine partetravirus) to 96.4% (between bovine
partetravirus HK1 and bovine partetravirus HK5).
Phylogenetic and sequence analysis
Phylogenetic inference was conducted on the multiple sequence
alignment of full-length NS1 and VP1/2 sequences of the
partetraviruses. The phylogenetic trees (Fig. 1 and 2) showed a
common topology, and placed the presently identified viruses in
the same clade as known partetraviruses. Bovine partetraviruses
HK4 and HK5 formed a cluster with known bovine partetra-
viruses, although the genetic distance between HK5 and the other
bovine partetraviruses suggested that it should be considered as a
different genotype of bovine partetravirus. The 4 identical strains
of ovine parvovirus are clearly shown to be distinct from the other
known partetraviruses, and are most closely related to bovine
partetraviruses. Based on these results, we recognize these ovine
parvoviruses as a new member of the partetraviruses and propose
to describe them as ovine partetraviruses. The phylogeny is
consistent with the hypothesis of virus-host co-evolution, as the
sheep and cattle are both ruminants and are evolutionarily closer
to each other than to the other hosts like pigs, chimpanzee and
humans.
Bootscan analysis on the genome sequences of PARV4-related
viruses highlighted some genomic regions that may have
undergone past recombination events between ovine parvovirus
and PARV4 (Fig. S1). GARD analysis on the DataMonkey server
(http://www.datamonkey.org/) also revealed the presence of 11
potential recombination breakpoints (data not shown), suggesting a
multitude of possible past recombination events. However,
incongruence testing with the Kishino-Hasegawa (KH) test failed
to confirm the presence of phylogenetic incongruence in the
partitions proposed by the bootscan and GARD analyses. Hence,
it is more likely that the potential recombination signals were false-
positives resulting from local differences in evolutionary rates
among different genes.
Sequence analysis for sites under positive selection revealed 1
site under positive selection in ORF1 and 13 sites under positive
selection in ORF2 (Table 3). No single site was shown to be under
positive selection by a consensus of all 3 methods (SLAC, FEL and
REL). The overall dN/dS as calculated by the SLAC method were
0.130 for both ORF1 and ORF2. The present results are
consistent with the biological functions of the viral proteins, as
VP2 (encoded by ORF2) is responsible for receptor binding and
would be under greater selection pressure for host adaptation and
immune evasion. The significance of these identified sites would
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require further knowledge of the structure and function of the viral
proteins for interpretation.
Discussion
The present study extends our previous discovery of parte-
traviruses in domestic animals. Although no clear association has
been found between clinical disease and human partetraviruses,
the relatively high prevalence of PARV4 in human blood products
has raised safety concerns, especially since available evidence
appears to support possible parenteral transmission of the virus
[14,36,37,38,39]. Similarly, animal partetraviruses have not been
found to be associated with any clinical diseases in the hosts, and
are detected frequently in apparently healthy animals [19,20,21].
So far, these viruses were mostly detected in liver, spleen, lymph
node and bone marrow, suggesting significant tropism for
lymphoid tissue, although there is also a report of detecting
PARV4 DNA at relatively high frequencies in other organs such as
the heart, lungs and kidneys [12]. The development of immune
electron microscopy and related techniques can determine the
intracellular location and cellular tropism of partetraviruses in
infected tissues, and success have been reported with the
visualization of PARV4 particles in a high-titre-positive plasma
sample [40]. This will aid efforts to target screening for subclinical
disease in patients or animals with positive partetravirus detection
by PCR or serology.
The understanding of parvovirus evolution has changed greatly
over the years. Initially, parvoviruses were thought to evolve slowly
relative to RNA viruses due to the utilization of the high-fidelity
host DNA polymerase during replication. This was also supported
by the very limited sequence diversity of the human pathogenic
parvovirus B19 that were known at the time. However, studies
examining the evolutionary rate of different parvoviruses suggested
that the evolutionary rates of parvoviruses are generally fast and
comparable to those of RNA viruses. Moreover, a broad range of
rates have been observed for different viruses: 1.761024
substitution/site/year (s/s/yr) in canine parvovirus, 9.461025 s/
s/yr in the closely related feline panleukopenia parvovirus [23],
8.661024 s/s/yr in human bocavirus [41], 161024 s/s/yr in
parvovirus B19 [42]. In particular, it has been inferred that the
evolutionary rate were as high as 0.727.161023 s/s/yr during the
time interval from which canine parvovirus emerged. The
discovery of additional genotypes of parvovirus B19 has also
bolstered the view of parvoviruses as fast-evolving viruses [43,44].
Nonetheless, questions remain on certain aspects of parvovirus
evolution. Although virus-host co-evolution had been proposed as
an important mechanism in the emergence of new animal
parvoviruses [22], this hypothesis cannot be easily reconciled with
Figure 1. Phylogenetic tree constructed from the full-length aa sequences of NS1 of partetraviruses and other parvoviruses.
Approximate likelihood SH-like support values .0.50 are shown besides major branches. NS1 aa sequences of bovine partetravirus HK1 to HK3 are
identical to that of bovine partetravirus HK4 and not shown. Scale bar indicates 0.5 inferred substitutions per site. Abbreviations: PPtV, porcine
partetravirus; BPtV, bovine partetravirus; OPtV, ovine partetravirus; PV, parvovirus; AAV, adeno-associated virus; BoV, bocavirus.
doi:10.1371/journal.pone.0025619.g001
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Figure 2. Phylogenetic tree constructed from the full-length aa sequences of VP1 of partetraviruses and other parvoviruses.
Approximate likelihood SH-like support values .0.50 are shown besides major branches. VP1 aa sequences of bovine partetravirus HK1 to HK3 are
identical to that of bovine partetravirus HK4 and not shown. Scale bar indicates 0.2 inferred substitutions per site. Abbreviations: PPtV, porcine
partetravirus; BPtV, bovine partetravirus; OPtV, ovine partetravirus; PV, parvovirus; AAV, adeno-associated virus; BoV, bocavirus.
doi:10.1371/journal.pone.0025619.g002
Table 3. Sites under positive selection in partetratvirus ORF1 and ORF2.
Sequence
Codon
position SLAC FEL REL
dN-dS p-value dN-dS p-value dN-dS Bayes factor
ORF1 675 2.993 0.308 0.548 0.071 20.569 1.0
ORF2 115 3.079 0.416 0.441 0.073 20.007 90.274
208 2.399 0.436 0.310 0.081 0.129 359.477
209 1.482 0.670 0.193 0.206 0.039 93.682
214 2.730 0.296 0.311 0.145 20.059 63.585
216 1.820 0.444 0.190 0.140 0.138 215.139
217 3.576 0.212 0.471 0.085 20.065 61.723
226 1.820 0.444 0.206 0.129 0.142 251.557
250 1.820 0.444 0.197 0.239 20.076 50.127
344 2.758 0.321 0.342 0.117 0.057 134.893
356 1.826 0.453 0.219 0.207 0.036 93.512
358 2.691 0.309 0.335 0.137 20.075 58.670
382 5.907 0.099 1.453 0.015 20.168 38.311
384 5.251 0.183 1.420 0.023 20.402 14.133
A p-value of ,0.1 is considered to be statistically significant for positive selection analysis by SLAC and FEL. A Bayes factor of .50 is considered statistically significant
for positive selection by REL.
doi:10.1371/journal.pone.0025619.t003
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the high evolutionary rates observed in diverse parvoviruses, as the
evolutionary timescale of the genetic distance between the animal
hosts would be several orders of magnitude greater than that of the
genetic distance between the corresponding parvoviruses. While
the effects of negative selection on parvoviruses highly adapted to
their animal host may slow further evolution of the virus, it is
unlike to account for the discrepancy between host and virus
evolution to a significant degree. In comparison, observations on
the emergence of canine parvovirus from feline panleukopenia
parvovirus [45] and the experimental cross-species infection of
rodent parvoviruses provide more support to the role of cross-
species transmission in the evolution of parvoviruses. This would
also be more consistent with the degree of recombination seen in
diverse parvoviruses [46], which would have required frequent
cross-species transmission and co-infection of different parvovi-
ruses in the same host [47].
The present detection of these partetraviruses in organs of
otherwise healthy animals suggests the possibility of viral
persistence, although comprehensive sampling of other sites such
as the respiratory tract would be needed to exclude acute
infections. Relatively little is known about persistence of
partetraviruses in animal hosts, although the phenomenon is
well-described for other parvoviruses. Genomic DNA of human
erythrovirus genotype 1 has been found to persist in the synovial
membranes of both patients with chronic arthropathy and healthy
individuals [48]. A larger study has additionally uncovered
information on the distribution and persistence among different
genotypes of human erythrovirus, which revealed the epidemio-
logical history of these genotypes in the human population [49].
The exact mechanism for viral persistence has not been fully
elucidated for many parvoviruses, though site-specific integration
has been described for adeno-associated viruses [50]. Among the
partetraviruses, the phenomenon of persistence is best studied in
the human partetravirus genotype PARV4, which has been found
in the blood, lymphoid tissue and bone marrow of HIV-infected
patients [12,18]. Results from interferon c enzyme-linked
immunospot assays suggested that PARV4 persistence may be
present at 26% of hepatitis C virus-positive individuals [51].
From the results of the current and previous studies, it is shown
that a diversity of partetraviruses could be found in humans and
other animals. As these viruses were only recently discovered, only
limited epidemiological and genetic data is available and they are
unlikely to reflect their true prevalence and genetic diversity.
Nonetheless, at least 3 genotypes have been identified for the
human partetravirus [52,53], which showed some degree of
geographic segregation in their circulation. In contrast, the porcine
partetraviruses identified in wild boars in Germany were highly
similar to the porcine partetraviruses initially discovered in Hong
Kong, though it remains possible to distinguish them as two close
clusters of viruses on a phylogenetic tree constructed from
discontinuous genome sequences [20]. The distinct cluster
formation by these related viruses on phylogenetic trees argue
for the consideration of the viruses to be classified in a new genus,
which has already been suggested in a current ICTV taxonomic
proposal. The present discovery of the ovine partetravirus and a
new genotype of bovine partetravirus adds to the diversity of
known partetraviruses, and should aid future efforts to character-
ize the evolution and transmission of these related viruses.
Supporting Information
Figure S1 Bootscan analysis on the genome sequences
of ovine partetravirus and related viruses (porcine
partetravirus HK7 (P), human partetravirus HK1 (H),
and bovine partetraviruses HK4 and HK5 (B)) using
Simplot version 3.5.1. Consensus threshold of 50% was
employed for analysing the bovine partetravirus sequences.
Parameters for the analysis are shown in the figure.
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